Epigenetic rewiring of pathways related to odour perception in immune cells exposed to SARS-CoV-2 in vivo and in vitroArticle Published on 2022-12-012023-07-09 Journal: Epigenetics [Category] [DOI] 10.1080/15592294.2022.2089471 PMC 바로가기
Efficacy of heterologous boosting against SARS-CoV-2 using a recombinant interferon-armed fusion protein vaccine (V-01): a randomized, double-blind and placebo-controlled phase III trial재조합 인터페론 무장 융합 단백질 백신(V-01)을 사용한 SARS-CoV-2에 대한 이종 부스팅의 효능: 무작위, 이중 맹검 및 위약 대조 3상 시험Clinical Trial Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2088406 PMC 바로가기 [Article Type] Clinical Trial
Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: Design, identification, and correlation with globally circulating viral genomesArticle Published on 2022-11-122022-11-15 Journal: Biochemical and Biophysical Research Communication [Category] [DOI] 10.1016/j.bbrc.2022.09.010 PMC 바로가기
Effectiveness of the neutralizing antibody sotrovimab among high-risk patients with mild-to-moderate SARS-CoV-2 in QatarArticle Published on 2022-11-012022-11-15 Journal: International Journal of Infectious Diseases [Category] [DOI] 10.1016/j.ijid.2022.09.023 PMC 바로가기
Bamlanivimab Use in a Military Treatment FacilityArticle Published on 2022-10-292022-11-15 Journal: Military Medicine [Category] [DOI] 10.1093/milmed/usab188 PMC 바로가기
Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 – United States, January-July 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] [DOI] 10.15585/mmwr.mm7143a2 PMC 바로가기
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a PartArticle Published on 2022-10-182022-11-15 Journal: Antimicrobial Agents and Chemotherapy [Category] [DOI] 10.1128/aac.00697-22 PMC 바로가기
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for useArticle Published on 2022-10-012022-11-15 Journal: European Journal of Clinical Pharmacology [Category] [DOI] 10.1007/s00228-022-03372-5 PMC 바로가기
Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variantArticle Published on 2022-10-012022-11-16 Journal: International forum of allergy & rhinology [Category] [DOI] 10.1002/alr.22995 PMC 바로가기
Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in Post COVID Syndrome correlate with symptom severityArticle Published on 2022-09-272022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.981532 PMC 바로가기